个人简介
After graduating with a master's degree from the Department of General Thoracic Surgery at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology in 2010, Dr. YOU Liangkun has worked in the Cardiothoracic Surgery Department at Wuhan General Hospital of Guangzhou Military Command. From 2012 to 2015, he pursued a Ph.D. in Oncology at Zhejiang University School of Medicine. Upon graduation in 2015, he began working in the Department of Medical Oncology at SRRSH. From 2018 to 2020, he conducted postdoctoral research at the Cancer Center, Massachusetts General Hospital, Harvard Medical School. His research focuses primarily on drug resistance in targeted therapies for lung cancer and melanoma, as well as RNA modifications and metabolism. Dr. You is currently a deputy chief physician in the Department of Medical Oncology and a member of the Mayo Clinic INTERCEPT international exchange program. He also served as a medical support staff member for the 2023 Asian Games in Hangzhou. He has led and participated in several projects funded by the National Natural Science Foundation of China and the Natural Science Foundation of Zhejiang Province and has been involved as a researcher in over a dozen international and global multicenter clinical studies.
学术任职
Member of the Expert Committee on Integrated Oncology and Nephrology of the Chinese Anti-Cancer Association (CACA)
Member of the Expert Committee on Nutritional Therapy for Tumors of the Chinese Society of Clinical Oncology (CSCO)
Member of the American Association for Cancer Research (AACR)
相关专家
-
WANG Xian Medical OncologyProfessor/Senior ConsultantPrevention, diagnosis and differential diagnosis of various malignant tumors as well as the chemotherapy and molecular targeted drug therapy of malignant tumors;preoperative neoadjuvant therapy of breast cancer, postoperative adjuvant therapy and comprehensive treatment of advanced breast cancer; clinical trials of novel antitumor drugs.
-
PAN Hongming Medical OncologySenior Consultant, professorDiagnosis, chemotherapy, targeting, immunization and radiofrequency ablation of various malignant tumors, and clinical trials of anti-tumor drugs.
-
FANG Yong Medical OncologySenior ConsultantMinimally invasive ablation of lung tumor; tumor biological immunotherapy; comprehensive treatment.
-
LI Da Medical OncologySenior ConsultantComprehensive treatment of lung cancer and digestive tract tumors, minimally invasive treatment of solid tumors and the treatment of drug toxicity and side effects, and drug resistance mechanism and delivery in vivo.
-
LOU Haizhou Medical OncologySenior ConsultantDiagnosis of various solid tumors, chemotherapy, targeted therapy, immunotherapy and integrated treatment of traditional Chinese and Western medicine, especially the comprehensive treatment of lung cancer and digestive tract tumors.
-
ZHENG Yu Medical OncologySenior ConsultantChemotherapy, targeted therapy and immunotherapy of lung cancer, digestive tract tumor and cancers of unknown primary; radiofrequency ablation of primary or metastatic tumor of liver; management of side effects of chemotherapy and supportive treatment; precise individualized treatment of gastric cancer and comprehensive treatment of liver and lung metastasis of colorectal cancer.
-
PAN Qin Medical OncologyConsultantStandardized diagnosis and treatment of tumor nutrition; diagnosis and treatment of malignant lymphoma; palliative care.
-
LOU Fang Medical OncologyConsultantDiagnosis of various solid tumors and the formulation of comprehensive treatment plans, especially the diagnosis, comprehensive treatment and clinical research of new drugs for malignant tumors such as melanoma, liver cancer, ovarian cancer and cervical cancer.
-
JIN Wei Medical OncologyConsultantA variety of common tumor diagnosis, chemotherapy, targeted therapy, immunotherapy and other individualized comprehensive treatment and minimally invasive radiofrequency therapy.
-
HU Hong Medical OncologyConsultantComprehensive diagnosis and treatment of common malignant tumors, tumor immunity and targeted therapy, tumor radiofrequency ablation, clinical research of new tumor drugs.
-
SHOU Jiawei Medical OncologyConsultantImmune and targeted therapy and drug resistance strategies for lung cancer; Tumor genetics and vaccines; Liver and gallbladder tumors; Tumor ablation techniques.
-
LU Haiqi Medical OncologyConsultantComprehensive treatment of common malignant tumors, with particular expertise in the diagnosis and precision treatment of breast, digestive system, and urinary system malignant tumors, as well as multiple primary tumors. She also specializes in research on drug resistance mechanisms and genetic screening for high-risk tumor populations.
-
ZHOU Xiaoyun Medical OncologyDeputy Chief PhysicianDiagnosis and treatment of ovarian cancer, lung cancer, gastric cancer, colon-rectal cancer, liver cancer, pancreatic cancer, breast cancer, especially the accurate treatment of ovary cancer, lung cancer and gastrointestinal tumors.
-
SHENG Jin Medical OncologyConsultantMolecular targeted therapy, chemotherapy, and immunotherapy for lung cancer, gastric cancer, colon cancer, pancreatic cancer, and malignant tumors with unknown primary focus; comprehensive treatment of solid tumors and case management, palliative care; molecular gene analysis and precision treatment of lung cancer and digestive tract tumors.
-
GONG Liu Medical OncologyConsultantLung cancer, neuroendocrine neoplasm, gastric cancer, colorectal cancer, hepatocarcinoma, pancreatic cancer, carcinoma of the bile duct and gynecological malignancies, especially the accurate treatment of NSCLC, SCLC and neuroendocrine neoplasm.
-
YAO Junlin Medical OncologyConsultantIntegrated management of malignant gastrointestinal tumors and breast cancer, including chemotherapy, targeted therapy, and immunotherapy for gastric cancer, colorectal cancer, liver cancer, cholangiocarcinoma, pancreatic cancer, esophageal cancer, and breast cancer; clinical research on novel drugs for advanced solid tumors.
-
ZHAI Chongya Medical OncologyConsultantComprehensive diagnosis and treatment of various solid tumors such as digestive tract malignant tumors and lung malignant tumors, as well as handling of adverse reactions to drugs.
-
WU Zhuoxuan Medical OncologyConsultantPrecision treatment of lung cancer and gastrointestinal tract tumors; holistic management of brain metastases; clinical trials of new drugs for solid tumors.
-
LI Hongsen Medical OncologyConsultantIndividualized treatment of malignant tumors of the respiratory and digestive tracts. Clinical research of new anti-tumor drugs.